Results reinforce that Amplatzer Piccoloâ„¢ Occluder is safe and effective for closing an opening in the heart known as a "patent ductus arteriosus" (PDA) in newborns Study found low adverse event rates ...
First and only delivery system designed specifically for premature infants with a patent ductus arteriosus (PDA), a life-threatening opening in their heart New delivery system enables precise ...
MEMPHIS, Tenn., Feb. 7, 2019 /PRNewswire/ -- Le Bonheur Children's Hospital cardiologists have implanted the world's first commercially-approved medical device for transcatheter patent ductus ...
The US Food and Drug Administration (FDA) has approved the Amplatzer Piccolo Occluder (Abbott), the first medical device to treat patent ductus arteriosus (PDA) in premature babies weighing as little ...
Abbott obtained US Food and Drug Administration (FDA) approval for its pea-sized Amplatzer Piccolo Occluder. This is the first medical device in the world to receive FDA approval for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results